In this study, we report that the upregulation of XPO1 expression in pancreatic cancer is, in part, due to the hypermethylation of the miR-30 family gene in cancer cells, leading to the downregulation of the miR-30 family and the upregulation of XPO1. The gene discussed is XPO1; the disease is pancreatic neoplasm.